WallStreetZenWallStreetZen

NASDAQ: ARTV
Artiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Artiva Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ra Capital Management LPDirector2026-06-16124,893$8.89
$1.11MBuy
Ra Capital Management LPDirector2026-06-1515,414$8.99
$138.57kBuy
Ra Capital Management LPDirector2026-06-12391,019$8.57
$3.35MBuy
Ra Capital Management LPDirector2026-06-11548,580$7.91
$4.34MBuy
Ra Capital Management LPDirector2026-06-10103$7.00
$721.00Buy
Ra Capital Management LPDirector2026-06-09479,039$6.91
$3.31MBuy
Heather RaymonSVP Research and Development2026-05-193,095$9.01
$27.88kSell
Fred AslanChief Executive Officer2026-05-1927,116$9.01
$244.26kSell
Subhashis BanerjeeChief Medical Officer2026-05-197,037$9.01
$63.39kSell
Jennifer BushCOO CLO Compliance Officer2026-05-198,790$9.01
$79.18kSell

1 of 4

ARTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARTV insiders and whales buy or sell their stock.

ARTV Shareholders

What type of owners hold Artiva Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP39.87%9,853,302$90.45MInstitution
Gc Corp24.27%5,999,703$55.08MInsider
Yongjun Huh19.89%4,916,249$45.13MInsider
5am Partners VI LLC9.52%2,353,304$21.60MInsider
5am Venture Management LLC9.52%2,353,304$21.60MInstitution
Venbio Global Strategic Fund III LP7.84%1,936,637$17.78MInsider
Venrock Adviser LLC6.51%1,609,569$14.78MInstitution
Fred Aslan6.21%1,535,082$14.09MInsider
Venbio Partners LLC2.15%531,337$4.88MInstitution
Franklin Resources Inc2.11%520,327$4.78MInstitution

1 of 3

ARTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTV47.77%52.23%Net BuyingNet Buying
IKT84.16%15.84%Net Buying
CLLS14.12%0.00%
FATE51.86%48.14%Net BuyingNet Buying
QTTB29.64%70.36%Net BuyingNet Buying
View Top Biotech Stocks

Artiva Biotherapeutics Stock Ownership FAQ

Who owns Artiva Biotherapeutics?

Artiva Biotherapeutics (NASDAQ: ARTV) is owned by 68.11% institutional shareholders, 74.46% Artiva Biotherapeutics insiders, and 0.00% retail investors. Gc Corp is the largest individual Artiva Biotherapeutics shareholder, owning 6.00M shares representing 24.27% of the company. Gc Corp's Artiva Biotherapeutics shares are currently valued at $53.46M.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.